Cytomegalovirus Antibodies And Herpes Zoster

Lab Reagents

Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus antibodies and herpes zoster reagents distributed by Genprice. The Cytomegalovirus Antibodies And Herpes Zoster reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Antibodies Group: And Herpes

And Herpes information

Cytomegalovirus Pp150 (UL32) Protein

20-abx260110 Abbexa
  • 1062.00 EUR
  • 410.40 EUR
  • 1646.40 EUR
  • 0.5 mg
  • 100 ug
  • 1 mg

Virus Cytomegalovirus (CMV) Protein

abx670257-1ml Abbexa 1 ml 493.2 EUR

Cytomegalovirus Glycoprotein Recombinant Protein

97-053 ProSci 0.05 mg 714.3 EUR
Description: Human cytomegalovirus is a species of the Cytomegalovirus genus of viruses, which in turn is a member of the viral family known as Herpesviridae or herpesviruses. It is typically abbreviated as HCMV or, commonly but more ambiguously, as CMV. CMV Virus Envelope Glycoportein B (CMV-GB) can be cleaved into glycoprotein GP55. Envelope glycoprotein that plays a role in host cell entry, cell to-cell virus transmission, and fusion of infected cells. CMV-GB may be involved in the initial attachment via binding to heparan sulfate together with the gM/gN complex that binds heparin with higher affinity. Furthermore, CMV-GB can interact with host integrin ITGB1, PDGFRA and EGFR that likely serve as postattachment entry receptors. Also, CMV-GB participates in the fusion of viral and cellular membranes leading to virus entry into the host cell. Membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL.

Cytomegalovirus UL83 recombinant antigen

8817 Virostat 100 ug 673.36 EUR
Description: This is Cytomegalovirus UL83 recombinant antigen for ELISA,WB.

Mouse antibody for Cytomegalovirus

887 Virostat 100 ug 431.93 EUR
Description: This is Mouse monoclonal FITC conjugated antibody against Cytomegalovirus pp65 for WB, ELISA.

Cytomegalovirus gB recombinant antigen

8965 Virostat 100 ug 608.1 EUR
Description: This is Cytomegalovirus gB recombinant antigen for ELISA,WB.

Cytomegalovirus p28 recombinant antigen

8966 Virostat 100 ug 608.1 EUR
Description: This is Cytomegalovirus p28 recombinant antigen for ELISA,WB.

Cytomegalovirus p150 recombinant antigen

8967 Virostat 100 ug 608.1 EUR
Description: This is Cytomegalovirus p150 recombinant antigen for ELISA,WB.

Anti-Human Cytomegalovirus antibody

STJ16100451 St John's Laboratory 1 mL 1092 EUR

Anti-Cytomegalovirus p65 antibody

STJ16101049 St John's Laboratory 100 µg 424.8 EUR

Anti-Cytomegalovirus p65 antibody

STJ16101050 St John's Laboratory 100 µg 424.8 EUR

Anti-Cytomegalovirus p65 antibody

STJ16101051 St John's Laboratory 100 µg 424.8 EUR

Cytomegalovirus Antibody / CMV / PP65

V2332-100UG NSJ Bioreagents 100 ug 499 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332-20UG NSJ Bioreagents 20 ug 219 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-100UG NSJ Bioreagents 100 ug 499 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-20UG NSJ Bioreagents 20 ug 219 EUR
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.